GEn1E Lifesciences Inc. (“Genie”) is a biotechnology company with a platform for accelerating cures for inflammatory and age-related diseases.

Why Us?

GEn1E team is experienced and well equipped to generate and execute development plans

Asset 5@2x.png

Why This?

Selectively screened programs with developmental and commercial attractiveness are optimized for rapid assessment of viability as potential commercial solutions

Asset 1@2x.png

Why Now?

Alignment of FDA incentives for areas of unmet medical need with selectively screened programs with significant market opportunities